Twin Peaks Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Twin Peaks Wealth Advisors's BMY Position: Q2 2026 in Review
Twin Peaks Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 1,697 shares — an estimated $103K sold.
Twin Peaks Wealth Advisors first reported a position in BMY in Q2 2025 and held it in 2 quarters. The position peaked at $103K in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Twin Peaks Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Twin Peaks Wealth Advisors sold 1,697 Bristol-Myers Squibb shares in Q2 2026, an estimated $103K.
- Twin Peaks Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2025 and held it in 2 quarters.
- Twin Peaks Wealth Advisors's Bristol-Myers Squibb position peaked at $103K in Q1 2026.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.